Mouse liver cancer cells (Hepa 1-6-EGFP)

The innovative application of Hepa 1-6-EGFP mouse liver cancer cells facilitates groundbreaking research in cancer biology by providing a robust model for studying tumor growth metastasis and the efficacy of new therapeutics These epithelial adherent cells preserved under optimal conditions using dry ice for transportation allow researchers to maintain cellular integrity and viability ensuring accurate experimental outcomes Leveraging a viral method for introduction of genetic modifications enhances the potential to investigate the molecular pathways involved in liver cancer progression which is crucial for developing targeted treatments Furthermore the use of a growth medium comprising 90% DMEM and 10% FBS supports robust cell propagation and functional assays enabling comprehensive exploration of drug responses and toxicity testing in a controlled environment Overall Hepa 1-6-EGFP mouse liver cancer cells represent a vital resource for advancing our understanding of hepatic malignancies and innovating therapeutic strategies